To obtain documents, log on:
:
Not registered? Register me now
 

Public Higher Education Bulletin

 
University of Illinois at Chicago
Exemption #351IDM

Announcement of an Exempt Purchase

Change Order
Published Saturday July 18, 2020
Vendor: Boston Scientific
Change Order Amount: $400,000
Increase in patient census requiring an increase in amount. See attached change order justification for details. End date changed to July 31, 2023.

The Chief Procurement Officer for this procurement is now John Donato.
The University award process may be delayed up to thirty days as this award goes through a state approval process.
Award Info Published Monday July 16, 2018
Awarded to:
Vendor: Boston Scientific, Marlborough, MA
Amount: An estimated $2,250,000
Terms:
An estimated start date of 7/16/2018 through 6/30/2023
Renewals:
None
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Monday, July 16, 2018
The University awarded a contract for WATCHMAN implant .
Boston Scientific Corporation and Subsidiaries? WATCHMAN implant is a left atrial appendage device which aids in stroke risk reduction and is an option for patients with non-valvular atrial fibrillation who are seeking an alternative to long-term warfarin therapy. The WATCHMAN implant is designed to close off the heart?s left atrial appendage, preventing the formation of blood clots that could lead to a stroke. The WATCHMAN LAA (Left Atrial Appendage) Closure Technology is intended to prevent thrombus embolization from the left atrial appendage and reduce the risk of life-threatening bleeding events in patients with non-valvular atrial fibrillation who are eligible for anticoagulation therapy or who have a contraindication to anticoagulation therapy. The WATCHMAN device is indicated to reduce the risk of thromboembolism from the left atrial appendage in patients with non-valvular atrial fibrillation who are at increased risk for stroke and systemic embolism based on CHADS2 or CHA2DS2-VASc scores, are deemed by their physicians to be unsuitable for warfarin, and have an appropriate rationale to seek a non-pharmacologic alternative to warfarin.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Boston Scientific?s implants have to do with direct patient care. Without access to these specific supplies the University of Illinois Hospital would not be able to offer surgical procedures and care, that in turn would drive patients elsewhere and result in a loss of revenue to the University of Illinois Hospital.

For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
Ian Masterton
University of Illinois at Chicago
Purchasing Division (M/C 560)
809 South Marshfield Avenue
Chicago, IL 60612
Phone: (312) 996-2801
FAX: (312) 996-3135

The State of Illinois has a policy to encourage prospective vendors to hire qualified veterans, minorities, females, persons with disabilities and ex-offenders.

Bulletin Navigation

 
To obtain documents, log on:
Exemption Document
  • Exemption351IDMBostonScientific.pdf (179 KB)
Other Public Documents
  • 351IDMExemptionChangeOrderFormSigned.pdf (493 KB)